Diagnostic tests for agents of community-acquired pneumonia

Clinical Infectious Diseases

Volumn 52, Issue SUPPL. 4, 2011, Pages

  Bartlett, John G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; ERYTHROMYCIN; NUCLEIC ACID;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BRONCHOSCOPY; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC TEST; EMPIRICISM; ENTEROBACTERIACEAE; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HEALTH CARE COST; HUMAN; LEGIONELLA PNEUMOPHILA; MEDICAID; MEDICARE; MYCOPLASMA PNEUMONIAE; NONHUMAN; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TRACHEAL ASPIRATION PROCEDURE; TRANSTHORACIC ASPIRATION; URINALYSIS; URINARY ANTIGEN TEST;

CLINICAL LABORATORY TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL;

EID: 79953801623     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir045     Document Type: Article

References (65)

1. Heffron R. Pneumonia, with special reference to pneumococcus lobar pneumonia. Cambridge, MA: Harvard University Press, 1979; 302-8.
2. Sullivan RJ Jr., Dowdle WR, Marine WM, Hierholzer JC. Adult pneumonia in a general hospital: etiology and host risk factors. Arch Intern Med 1972; 129:935-42.
3. Austrian R. Of Man and pneumococcus, an historical paradox. In: Borek E, Monod J, eds. Of microbes and life. New York and London: Columbia University Press, 1971: 165-73.
4. Bullowa JGM. The reliability ofsputum typing and its relation to serum therapy. JAMA 1935; 105:1512-23.
5. Avery OT, Chickering HT, Cole R, Dochez AR. Acute lobar pneumo-nia: prevention and serum treatment. Rockefeller Inst Med Res 1917; 119:110.
6. Cecil RL, Baldwin HS, Larsen NP. Clinical and bacteriologic study of 2000 typed cases oflobar pneumonia. Arch Intern Med 1927; 40:253.
7. Sutliff WD, Finland M. The significance of the newly classified types in disease, types IV to XX inclusive. N Engl J Med 1934; 210:237.
8. Mundy LM, Auwaerter PG, Oldach D, et al; Communityacquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995; 152:1309-15.
9. Fiala M. A study of the combined role of viruses, mycoplasmas and bacteria in adult pneumonia. Am J Med Sci 1969; 257:44-51.
10. Fekety FR Jr., Caldwell J, Gump D, et al; Bacteria, viruses, and myco-plasmas in acute pneumonia in adults. Am Rev Respir Dis 1971; 104:499-507.
11. Dans PE, Charache PC, Fahey M, Otter SE. Management of pneumonia in the prospective payment era: a need for more clinician and support service interaction. Arch Intern Med 1984; 144:1392-7. (Pubitemid 14087066)
12. The British Thoracic Society, Public Health Laboratory Service. Communityacquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 1987; 62:195-220.
13. Holmberg H. Aetiology of community acquiredpneumonia in hospital treated patients. Scand J Infect Dis 1987; 19:491-501. (Pubitemid 17149062)
14. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1:671-4. (Pubitemid 17038913)
15. Lévy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia: importance of initial noninvasive bacteriologic and radiographic investigations. Chest 1988; 93:43-8. (Pubitemid 18037254)
16. Fang GD, Fine M, Orloff J, et al; New and emerging etiologies for communityacquired pneumonia with implication for therapy: a pro-spective multicenter study of 359 cases. Medicine 1990; 69:307-16. (Pubitemid 20360038)
17. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for communityacquired pneumonia. Ann Intern Med 1991; 115:428-36.
18. Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring ad-mission to hospital. Thorax 1995; 50:543-7.
19. Park DR, Sherbin VL, Goodman MS, et al; Harborview CAP study group. The etiology of communityacquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity ofillness. J Infect Dis 2001; 184:268-77. (Pubitemid 32662172)
20. File TM. Communityacquired pneumonia. Lancet 2003; 362:1991-2001.
21. Bartlett JG, Finegold SM. Bacteriology ofexpectorated sputum with quantitative culture and wash technique compared to transtracheal aspiration. Am Rev Respir Dis 1978; 117:1019-27. (Pubitemid 8380198)
22. Musher DM, Montoya R, Wanahita A. Diagnostic value ofmicroscopic examination of gramstained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2004; 39:165-9. (Pubitemid 38971484)
23. Bartlett JG, Finegold SM. Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. Am Rev Respir Dis 1978; 117:1019-27. (Pubitemid 8380198)
24. Murray PR, Washington JA II. Microscopic and bacteriologic analysis ofexpectorated sputum. Mayo Clin Proc 1975; 50:339-44.
25. Van Scoy RE. Bacterial sputum cultures: a clinician's viewpoint. Mayo Clin Proc 1977; 52:39-41. (Pubitemid 8055284)
26. Geckler RW, Gremillion DH, McAllister CK, Ellenbogen C. Micro-scopic and bacteriological comparison of paired sputa and trans-tracheal aspirates. J Clin Microbiol 1977; 6:396-9. (Pubitemid 8202544)
27. Washington JA. Noninvasive diagnostic techniques for lower respiratory infections. In: Pennington J, ed. Respiratory infections: diagnosis, management. 3rd ed. New York: Raven Press, Ltd, 1994: 55-71.
28. Ingram JG, Plouffe JF. Danger ofsputum purulence screens in culture of Legionella species.J Clin Microbiol 1994; 32:209-10. (Pubitemid 24016811)
29. Chuard C, Fracheboud D, Regamey C. Effect of sputum induction by hypertonic saline on specimen quality. Diagn Microbiol Infect Dis 2001; 39:211-4. (Pubitemid 32524257)
30. Pecora DV, Yegian D. Bacteriology of lower respiratory tract in health and chronic disease. N Engl J Med 1958; 258:71-4.
31. Hoeprich PD. Etiologic diagnosis of lower respiratory tract infections. Calif Med 1970; 112:1-8.
32. Pratter MR, Irwin RS. Transtracheal aspiration: guidelines for safety. Chest 1979; 76:518-20.
33. Bartlett JG. Diagnostic accuracy of transtracheal aspiration bacterio-logic studies. Am Rev Respir Dis 1977; 115:777-82. (Pubitemid 8102624)
34. Hahn HH, Beaty HN. Transtracheal aspiration in the evaluation of patients with pneumonia. Ann Intern Med 1970; 72:183-7.
35. Kalinske RW, Parker RH, Brandt E. Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med 1970; 276:604-8.
36. Pecora DV. A comparison of transtracheal aspiration with other methods of determining the bacterial flora and the lower respiratory tract. N Engl J Med 1963; 296:664-6.
37. Bjerkestrand G, Digranes A, Schreiner A. Bacteriological findings in transtracheal aspirates from patients with chronic bronchitis and bronchiectasis. Scand J Resp Dis 1975; 56:201-7.
38. Brook I. Percutaneous transtracheal aspiration in the diagnosis and treatment of aspiration pneumonia in children. J Pediatr 1980; 96: 1000-04. (Pubitemid 10068833)
39. Leyden I VII. Verhandlungen des Vereins fur innere Medicin: ueber infectiose pneumonie. Deutsch Med Wschr 1883; 9:52-4.
40. Bartlett JG. Invasive diagnostic techniques in pulmonary infections. In: Pennington J, ed. Respiratory infections: diagnosis and management, 3rd ed. New York: Raven Press, Ltd, 1994: 73-99.
41. Bartlett JG, Alexander J, Mayhew J, Sullivan-Sigler N, Gorbach SL. Should fiberoptic bronchoscopy aspirates be cultures? Am Rev Respir Dis 1976; 114:73-8.
42. Wimberly NW, Faling J, Bartlett JG. A fiberoptic bronchoscopy tech-nique to obtain uncontaminated lower airway secretions for bacterial culture. Am Rev Respir Dis 1979; 119:337-43. (Pubitemid 9131379)
43. Wimberly NW, Bass JB, Boyd BW, et al; Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections. Chest 1982; 81:556-62. (Pubitemid 12112322)
44. Bartlett JG. Diagnostic test for etiologic agent of communityacquired pneumonia. Infect Dis Clin N Am 2004; 18:809-27. (Pubitemid 39536010)
45. Fine MJ, Smith MA, Carson CA, et al; Prognosis and outcomes of patients with communityacquired pneumonia: a metaanalysis. JAMA 1996; 275:134-41.
46. Smith MD, Derrington P, Evans R, et al; Rapid diagnosis ofbacteremic pneumococcal infections in adults by using the Binax NOW Strepto-coccus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol 2003; 41:2810-3. (Pubitemid 36842263)
47. Bartlett JG. Is activity against "atypical" pathogens necessary in the treatment protocols for communityacquired pneumonia? Issues with combination therapy. CID 2008; 47:(suppl 3):S232-6.
48. Smith MD, Sheppard CL, Hogan A, et al; Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and com-munityacquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection. J Clin Microbiol 2009; 47:1046-9.
49. Joseph JA. Legionnaires' disease in Europe 2000-2002. Epidemiol In-fect 2004; 132:417-24.
50. Diederen BM. Legionella spp. and Legionnaires' disease.J Infect 2008; 56:1-12. (Pubitemid 350253650)
51. Helbig JH, Uldum SA, Bernander S, et al; Clinical utility of urinary antigen detection for diagnosis of communityacquired, travel-associated, and nosocomial Legionnaires' disease. J Clin Microbiol 2003; 41:838-40. (Pubitemid 36184210)
52. Murdoch DR. Diagnosis of Legionella infection. Clin Infect Dis 2003; 36:64-9. (Pubitemid 36099099)
53. Dowell SF, Peeling RW, Boman J, et al; Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33:492-503.
54. Apfalter P, Blasi F, Boman J, et al; Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol 2001; 39:519-24. (Pubitemid 32150811)
55. Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis 2007; 44:568-76. (Pubitemid 46233262)
56. Wang W, Ren P, Sheng J, et al; Simultaneous detection ofrespiratory viruses in children with acute respiratory infection using two different multiplex reverse transcription-PCR assays. J Virol Methods 2009; 162:40-5.
57. Ginocchio CC, Zhang F, Manji R, et al; Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak.J Clin Virol 2009; 45:191-5.
58. Wong S, Pabbaraju K, Lee BE, Fox JD. Enhanced viral ethiological diagnosis of respiratory system infection outbreaks by use of a multi-target nucleic acid amplification assay. J Clin Microbiol 2009; 47:3839-45.
59. Jiang T, Kang X, Deng Y, et al; Development of a realtime RTPCR assay for a novel influenza A (H1N1) virus. J Virol Methods 2010; 163:470-3.
60. Krizek TJ, Robson MC. Biology of surgical infection. Surg Clin North Am 1975; 55:1261-7.
61. Canadian Critical Care Trials Group. A randomized trial ofdiagnostic techniques for ventilatorassociated pneumonia. N Engl J Med 2006; 355:2619-30.
62. Chastre J, Fagon JY, Bornet Lecso M, et al; Evaluation of broncho-scopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 152:231-40.
63. Fagon JY, Chastre J, Wolff M, et al; Invasive and noninvasive strategies for management of suspected ventilatorassociated pneumonia: a ran-domized trial. Ann Intern Med 2000; 132:621-30. (Pubitemid 30217554)
64. Lindenauer PK, Remus D, Roman S, et al; Public reporting and pay for performance in hospital quality improvement. N Engl J Med 2007; 356:486-96. (Pubitemid 46193076)
65. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing ofanti-biotic administration and outcomes for Medicare patients hospitalized with communityacquired pneumonia. Arch Intern Med 2004; 164:637-44. (Pubitemid 38392978)